SPARC Q2 loss widens to Rs 63 cr

Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the ongoing fiscal. The company had reported a loss of Rs 2.58 crore for July-September, 2018-19.

Total income declined to Rs 19.45 crore during the second quarter as compared with Rs 65.92 crore in the year-ago period, SPARC said in a regulatory filing. Shares of SPARC were trading at Rs 146.7 apiece, up 2.34 per cent on the BSE.